Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiejun Wu

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Journal of Biomolecular Screening|June 6, 2009
Characterization of a robust enzymatic assay for inhibitors of 2-oxoglutarate-dependent hydroxylasesKimon C Kanelakis, Heather L Palomino, Lina Li, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2007
Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysisLaurent Gomez, Michael D Hack, Jiejun Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 21, 2025
Wafer Scale III-Nitride Deep-Ultraviolet Vertical-Cavity Surface-Emitting Lasers Featuring Nanometer-Class Control of Cavity LengthChen Ji, Jiaming Wang, Fujun Xu, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2008
Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolaseJohn M Keith, Richard Apodaca, Wei Xiao, et al.
Anesthesia and Analgesia|December 20, 2008
Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolaseMark J Karbarz, Lin Luo, Leon Chang, et al.
Bioorganic & Medicinal Chemistry|February 22, 2008
Discovery of potent cholecystokinin-2 receptor antagonists: elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysisMark D Rosen, Michael D Hack, Brett D Allison, et al.
Molecular Pharmacology|September 10, 2015
GPR139, an Orphan Receptor Highly Enriched in the Habenula and Septum, Is Activated by the Essential Amino Acids L-Tryptophan and L-PhenylalanineChanglu Liu, Pascal Bonaventure, Grace Lee, et al.
The Journal of Biological Chemistry|July 4, 2007
R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterizationChester Kuei, Steven Sutton, Pascal Bonaventure, et al.
Nature Biotechnology|June 17, 2020
Directed remodeling of the mouse gut microbiome inhibits the development of atherosclerosisPoshen B Chen, Audrey S Black, Adam L Sobel, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 10, 2009
Modulation of DNA methylation by a sesquiterpene lactone parthenolideZhongfa Liu, Shujun Liu, Zhiliang Xie, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Journal of Biomolecular Screening|June 6, 2009
Characterization of a robust enzymatic assay for inhibitors of 2-oxoglutarate-dependent hydroxylasesKimon C Kanelakis, Heather L Palomino, Lina Li, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2007
Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysisLaurent Gomez, Michael D Hack, Jiejun Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 21, 2025
Wafer Scale III-Nitride Deep-Ultraviolet Vertical-Cavity Surface-Emitting Lasers Featuring Nanometer-Class Control of Cavity LengthChen Ji, Jiaming Wang, Fujun Xu, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2008
Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolaseJohn M Keith, Richard Apodaca, Wei Xiao, et al.
Anesthesia and Analgesia|December 20, 2008
Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolaseMark J Karbarz, Lin Luo, Leon Chang, et al.
Bioorganic & Medicinal Chemistry|February 22, 2008
Discovery of potent cholecystokinin-2 receptor antagonists: elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysisMark D Rosen, Michael D Hack, Brett D Allison, et al.
Molecular Pharmacology|September 10, 2015
GPR139, an Orphan Receptor Highly Enriched in the Habenula and Septum, Is Activated by the Essential Amino Acids L-Tryptophan and L-PhenylalanineChanglu Liu, Pascal Bonaventure, Grace Lee, et al.
The Journal of Biological Chemistry|July 4, 2007
R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterizationChester Kuei, Steven Sutton, Pascal Bonaventure, et al.
Nature Biotechnology|June 17, 2020
Directed remodeling of the mouse gut microbiome inhibits the development of atherosclerosisPoshen B Chen, Audrey S Black, Adam L Sobel, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 10, 2009
Modulation of DNA methylation by a sesquiterpene lactone parthenolideZhongfa Liu, Shujun Liu, Zhiliang Xie, et al.
Pageof 7